Author:
Kaemmerer Daniel,Twrznik Matthias,Kulkarni Harshad R.,Hörsch Dieter,Sehner Susanne,Baum Richard P.,Hommann Merten
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference62 articles.
1. Phase 3 trial of (177)Lu-Dotatate for midgut neuroendocrine tumors;Strosberg;N Engl J Med,2017
2. Treatment with the radiolabeled somatostatin analog [177Lu–DOTA0,Tyr3]octreotate: toxicity, efficacy, and survival;Kwekkeboom;J Clin Oncol,2008
3. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs;Kwekkeboom;J Nucl Med,2005
4. Neuroendocrine tumors. Peptide receptor radionuclide therapy;Forrer;Best Pract Res,2007
5. Pancreatic neuroendocrine neoplasms;Horsch;Minerva Gastroenterol Dietol,2012
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献